Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain.
Baïssas T, Boisnard F, Cuesta Esteve I, Garcia Sánchez M, Jones CE, Rigoine de Fougerolles T, Tan L, Vitoux O, Klein C. Baïssas T, et al. Among authors: boisnard f. BMC Public Health. 2021 Nov 29;21(1):2182. doi: 10.1186/s12889-021-12198-2. BMC Public Health. 2021. PMID: 34844567 Free PMC article. Review.
Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age.
Langue J, Matisse N, Pacoret P, Undreiner F, Boisnard F, Soubeyrand B; Pentavac study group. Langue J, et al. Among authors: boisnard f. Vaccine. 2004 Mar 29;22(11-12):1406-14. doi: 10.1016/j.vaccine.2003.10.026. Vaccine. 2004. PMID: 15063563 Clinical Trial.
DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
Lee AW, Jordanov E, Boisnard F, Marshall GS. Lee AW, et al. Among authors: boisnard f. Expert Rev Vaccines. 2017 Feb;16(2):85-92. doi: 10.1080/14760584.2017.1268920. Epub 2016 Dec 20. Expert Rev Vaccines. 2017. PMID: 27996332 Review.
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series.
Oliver JL, Sadorge C, Boisnard F, Snape MD, Tomlinson R, Mann R, Rudd P, Bhakthavalsala S, Faust SN, Heath PT, Hughes SM, Borrow R, Thomas S, Finn A. Oliver JL, et al. Among authors: boisnard f. Vaccine. 2020 Jul 31;38(35):5718-5725. doi: 10.1016/j.vaccine.2020.06.015. Epub 2020 Jul 10. Vaccine. 2020. PMID: 32654902 Clinical Trial.
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Kitchin N, Southern J, Morris R, Borrow R, Fiquet A, Boisnard F, Thomas S, Miller E. Kitchin N, et al. Among authors: boisnard f. Vaccine. 2009 Aug 13;27(37):5096-102. doi: 10.1016/j.vaccine.2009.06.049. Epub 2009 Jun 30. Vaccine. 2009. PMID: 19573637 Clinical Trial.
Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age.
Vesikari T, Silfverdal SA, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Vesikari T, et al. Among authors: boisnard f. Clin Vaccine Immunol. 2013 Oct;20(10):1647-53. doi: 10.1128/CVI.00414-13. Epub 2013 Aug 21. Clin Vaccine Immunol. 2013. PMID: 23966556 Free PMC article. Clinical Trial.
Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster.
Mallet E, Matisse N, Mathieu N, Langue J, Boisnard F, Soubeyrand B; Pentavac Study Group. Mallet E, et al. Among authors: boisnard f. Vaccine. 2004 Mar 29;22(11-12):1415-22. doi: 10.1016/j.vaccine.2003.10.025. Vaccine. 2004. PMID: 15063564 Clinical Trial.
19 results